BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 18261829)

  • 21. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
    Li W; Murthy AK; Guentzel MN; Seshu J; Forsthuber TG; Zhong G; Arulanandam BP
    J Immunol; 2008 Mar; 180(5):3375-82. PubMed ID: 18292563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlamydial genomics and vaccine antigen discovery.
    Stephens RS
    J Infect Dis; 2000 Jun; 181 Suppl 3():S521-3. PubMed ID: 10839752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
    FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library.
    Goodall JC; Yeo G; Huang M; Raggiaschi R; Gaston JS
    Eur J Immunol; 2001 May; 31(5):1513-22. PubMed ID: 11465108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice.
    Perry LL; Feilzer K; Portis JL; Caldwell HD
    J Immunol; 1998 Mar; 160(6):2905-14. PubMed ID: 9510194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.
    Forsbach-Birk V; Simnacher U; Pfrepper KI; Soutschek E; Kiselev AO; Lampe MF; Meyer T; Straube E; Essig A
    Clin Microbiol Infect; 2010 Aug; 16(8):1237-44. PubMed ID: 19723133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.
    Penttilä T; Wahlström E; Vuola JM; Sarvas M; Puolakkainen M
    Comp Med; 2006 Aug; 56(4):272-8. PubMed ID: 16941954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.
    Russell AN; Zheng X; O'Connell CM; Wiesenfeld HC; Hillier SL; Taylor BD; Picard MD; Flechtner JB; Zhong W; Frazer LC; Darville T
    J Infect Dis; 2016 Dec; 214(12):1884-1892. PubMed ID: 27738051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera.
    Sanchez-Campillo M; Bini L; Comanducci M; Raggiaschi R; Marzocchi B; Pallini V; Ratti G
    Electrophoresis; 1999 Aug; 20(11):2269-79. PubMed ID: 10493131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis.
    Gaston JS; Deane KH; Jecock RM; Pearce JH
    J Rheumatol; 1996 Jan; 23(1):130-6. PubMed ID: 8838521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an in vivo CD4+ T cell-mediated response to polymorphic membrane proteins of Chlamydia pneumoniae during experimental infection.
    Mygind T; Vandahl B; Pedersen AS; Christiansen G; Höllsberg P; Birkelund S
    FEMS Immunol Med Microbiol; 2004 Mar; 40(2):129-37. PubMed ID: 14987731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlamydia vaccine candidates and tools for chlamydial antigen discovery.
    Rockey DD; Wang J; Lei L; Zhong G
    Expert Rev Vaccines; 2009 Oct; 8(10):1365-77. PubMed ID: 19803759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of CT521 as a frequent target of Th1 cells in patients with urogenital Chlamydia trachomatis infection.
    Olsen AW; Follmann F; Jensen K; Højrup P; Leah R; Sørensen H; Hoffmann S; Andersen P; Theisen M
    J Infect Dis; 2006 Nov; 194(9):1258-66. PubMed ID: 17041852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins.
    Sharma J; Zhong Y; Dong F; Piper JM; Wang G; Zhong G
    Infect Immun; 2006 Mar; 74(3):1490-9. PubMed ID: 16495519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.
    Murthy AK; Cong Y; Murphey C; Guentzel MN; Forsthuber TG; Zhong G; Arulanandam BP
    Infect Immun; 2006 Dec; 74(12):6722-9. PubMed ID: 17015458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.
    Finco O; Frigimelica E; Buricchi F; Petracca R; Galli G; Faenzi E; Meoni E; Bonci A; Agnusdei M; Nardelli F; Bartolini E; Scarselli M; Caproni E; Laera D; Zedda L; Skibinski D; Giovinazzi S; Bastone R; Ianni E; Cevenini R; Grandi G; Grifantini R
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9969-74. PubMed ID: 21628568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic profiling of a Chlamydia trachomatis gene-expression library.
    Follmann F; Olsen AW; Jensen KT; Hansen PR; Andersen P; Theisen M
    J Infect Dis; 2008 Mar; 197(6):897-905. PubMed ID: 18288899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection.
    Murdin AD; Dunn P; Sodoyer R; Wang J; Caterini J; Brunham RC; Aujame L; Oomen R
    J Infect Dis; 2000 Jun; 181 Suppl 3():S544-51. PubMed ID: 10839756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological response to pgp3 protein in animal and human chlamydial infections.
    Donati M; Laroucau K; Storni E; Mazzeo C; Magnino S; Di Francesco A; Baldelli R; Ceglie L; Renzi M; Cevenini R
    Vet Microbiol; 2009 Mar; 135(1-2):181-5. PubMed ID: 18945555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
    Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.